Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #: Z014503, Exp 11/15/2027
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Merck Sharp & Dohme LLC
- Reason for Recall:
- Presence of particulate matter: potential presence of metal particulates in the product.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- ongoing
Product Information
Full Description:
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Product Codes/Lot Numbers:
Lot #: Z014503, Exp 11/15/2027
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0241-2026
Related Recalls
Presence of particulate matter: potential presence of metal particulates in the product.
Presence of foreign substance: Presence of stainless steel particulates in tablets.
Presence of Particulate Matter: Identified as Glass Particles